Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Clinical background factors affecting outcomes of Helicobacter pylori eradication therapy in primary care

View through CrossRef
AbstractObjectiveFew studies have reported the influence of clinical background factors on the outcome of Helicobacter pylori eradication therapy in primary care practice. We aimed to determine which clinical background factors influence the outcome of eradication therapy in a primary care setting.MethodsThis was a retrospective study of patients who received H pylori eradication therapy at Higashiohmi City Gamo Medical Center, Shiga, Japan, from January 2012 to December 2015. We investigated clinical background factors associated with success, failure, and self‐interruption of H pylori eradication therapy: patients’ age, gender, first‐ or second‐line treatment, reasons for receiving gastroenterological endoscopic examination, method of drug administration, and attending physicians’ age and their specialties.ResultsThere were 369 patients (208 females, 161 male), with a mean age of 59 years (range 30‐88 years). The middle‐aged group (50‐69 years) was associated with successful eradication therapy compared with the young group (30‐49 years). The elderly group (>70 years) was associated with eradication therapy failure compared with the middle‐aged group. The young group was associated with self‐interruption of eradication therapy. There was a marginally significant association between male patients and self‐interruption. Older attending physicians (>50 years) were also associated with failure compared with younger physicians. There was no difference in outcome of eradication therapy between generalists and gastroenterology specialists.ConclusionWe have identified clinical factors associated with success, failure, and self‐interruption of H pylori eradication therapy in a primary care setting.
Title: Clinical background factors affecting outcomes of Helicobacter pylori eradication therapy in primary care
Description:
AbstractObjectiveFew studies have reported the influence of clinical background factors on the outcome of Helicobacter pylori eradication therapy in primary care practice.
We aimed to determine which clinical background factors influence the outcome of eradication therapy in a primary care setting.
MethodsThis was a retrospective study of patients who received H pylori eradication therapy at Higashiohmi City Gamo Medical Center, Shiga, Japan, from January 2012 to December 2015.
We investigated clinical background factors associated with success, failure, and self‐interruption of H pylori eradication therapy: patients’ age, gender, first‐ or second‐line treatment, reasons for receiving gastroenterological endoscopic examination, method of drug administration, and attending physicians’ age and their specialties.
ResultsThere were 369 patients (208 females, 161 male), with a mean age of 59 years (range 30‐88 years).
The middle‐aged group (50‐69 years) was associated with successful eradication therapy compared with the young group (30‐49 years).
The elderly group (>70 years) was associated with eradication therapy failure compared with the middle‐aged group.
The young group was associated with self‐interruption of eradication therapy.
There was a marginally significant association between male patients and self‐interruption.
Older attending physicians (>50 years) were also associated with failure compared with younger physicians.
There was no difference in outcome of eradication therapy between generalists and gastroenterology specialists.
ConclusionWe have identified clinical factors associated with success, failure, and self‐interruption of H pylori eradication therapy in a primary care setting.

Related Results

The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
<p dir="ltr"><b>Background</b></p><p dir="ltr">Helicobacter pylori (H. pylori) infects nearly half of the world's population and causes gastritis, pep...
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
The role of helicobacter pylori in coronary heart disease : laboratory, observational, and interventional studies
<p dir="ltr"><b>Background</b></p><p dir="ltr">Helicobacter pylori (H. pylori) infects nearly half of the world's population and causes gastritis, pep...
Different regimens for eradication of Helicobacter pylori infection in children: a randomized controlled trial
Different regimens for eradication of Helicobacter pylori infection in children: a randomized controlled trial
Abstract Eradication of Helicobacter pylori (H. pylori) infection in children is challenging due to increased antibiotic resistance and decreased effectiveness of the cur...
Helicobacter pylori infection and related factors among pregnant women at Debre Tabor General Hospital, Northwest Ethiopia, 2021
Helicobacter pylori infection and related factors among pregnant women at Debre Tabor General Hospital, Northwest Ethiopia, 2021
Abstract Introduction: Infection with Helicobacter pylori is one of the most frequent chronic bacterial illnesses in humans, infecting more than half of the world's populat...
Helicobacter pylori and gastric cancer
Helicobacter pylori and gastric cancer
Introduction: According to GLOBOCAN estimates for 2018, gastric cancer was the fifth most common cancer and the third most common cause of death from malignant diseases in the worl...

Back to Top